Shares of Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) have earned a consensus rating of “Buy” from the seven brokerages that are covering the stock, MarketBeat.com reports. Six research ...
Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report). The ...
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Solid Biosciences (SLDB – Research Report) today and set a price target of ...
Barclays started coverage on shares of VICI Properties (NYSE:VICI – Free Report) in a research note published on Friday, ...
The Pangisdaan Festival is just one of the many activities that the local government laid out for the commemoration of its 119th founding anniversary towards promoting the identity of Navotas as the ...
Upon its completion in July 2022, the LaGuardia Terminal B redevelopment project led as a P3 between LaGuardia Gateway ...
The Magnificent 7 group of stocks again proved their dominance in 2024. With an average gain of 63% in the year, they ...
The Mail On Sunday reports claims that Dominic Cummings is helping orchestrate Elon Musk's attacks on British politicians including Sir Keir Starmer. Rachel Reeves will launch a war on waste to ...
One of the two North Korean soldiers captured by Ukraine has claimed during questioning that he thought he was going for training, not to the war against Ukraine, Kyiv's security s... The former head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback